Breaking News Instant updates and real-time market news.

UDR

UDR

$46.30 /

+0.045 (+0.10%)

09:16
06/30/22
06/30
09:16
06/30/22
09:16

UDR price target lowered to $41 from $51 at Jefferies

Jefferies analyst Jonathan Petersen lowered the firm's price target on UDR to $41 from $51 and keeps a Hold rating on the shares. Petersen and the team believe REITs underperforming in a looming recession is "not a given," noting that real estate demonstrated "robust returns" during past stagflation periods. The analysts, who are making a number of price target and rating changes among their REITS coverage, recommend property types with rent inflation potential to offsets occupancy pressures, such as Industrial, Storage, Residential, DCs, Towers, and Senior Housing.

  • 30

    Mar

OTHER BREAKING NEWS FROM THE FLY

Options
Size spread in ChargePoint adjusts large position reset yesterday » 11:00
08/09/22
08/09
11:00
08/09/22
11:00
CHPT

ChargePoint

$15.45 /

-0.53 (-3.32%)

Size spread in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

07/18/22 Fox Advisors
ChargePoint upgraded to Overweight from Equal Weight at Fox Advisors
07/14/22 JPMorgan
ChargePoint risk/reward attractive for long-term investors, says JPMorgan
06/22/22 Stifel
ChargePoint price target lowered to $26 from $32 at Stifel
06/17/22 B. Riley
ChargePoint initiated with Buy on 'dominant' market share at B. Riley
CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

CHPT ChargePoint
$15.45 /

-0.53 (-3.32%)

Conference/Events
JPMorgan private markets analysts hold analyst/industry conference call » 10:59
08/09/22
08/09
10:59
08/09/22
10:59

Global Head of Private…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Kohl's put volume heavy and directionally bearish » 10:55
08/09/22
08/09
10:55
08/09/22
10:55
KSS

Kohl's

$30.22 /

-1.23 (-3.91%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KSS Kohl's
$30.22 /

-1.23 (-3.91%)

KSS Kohl's
$30.22 /

-1.23 (-3.91%)

08/04/22 Cowen
Kohl's downgraded to Market Perform on consumer pressure at Cowen
08/04/22 Cowen
Kohl's downgraded to Market Perform from Outperform at Cowen
07/26/22 Deutsche Bank
Walmart outlook 'red flag for apparel,' says Deutsche Bank
07/15/22 UBS
Kohl's price target lowered to $20 from $32 at UBS
KSS Kohl's
$30.22 /

-1.23 (-3.91%)

KSS Kohl's
$30.22 /

-1.23 (-3.91%)

KSS Kohl's
$30.22 /

-1.23 (-3.91%)

KSS Kohl's
$30.22 /

-1.23 (-3.91%)

Hot Stocks
WeTrade Group Inc trading resumes  10:54
08/09/22
08/09
10:54
08/09/22
10:54
WETG

WeTrade

$17.20 /

-1 (-5.49%)

 
ShowHide Related Items >><<
WETG WeTrade
$17.20 /

-1 (-5.49%)

  • 19
    Jul
Initiation
Holley initiated with an Outperform at Imperial Capital » 10:51
08/09/22
08/09
10:51
08/09/22
10:51
HLLY

Holley

$5.99 /

-0.22 (-3.54%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLLY Holley
$5.99 /

-0.22 (-3.54%)

HLLY Holley
$5.99 /

-0.22 (-3.54%)

07/29/22 Jefferies
Holley downgraded to Hold on business deceleration at Jefferies
07/29/22 JPMorgan
Holley downgraded to Neutral from Overweight at JPMorgan
07/29/22 Jefferies
Holley downgraded to Hold from Buy at Jefferies
06/28/22 JPMorgan
Holley initiated with an Overweight at JPMorgan
HLLY Holley
$5.99 /

-0.22 (-3.54%)

  • 21
    Apr
HLLY Holley
$5.99 /

-0.22 (-3.54%)

General news
Wall Street is turning lower » 10:50
08/09/22
08/09
10:50
08/09/22
10:50
$ECON

Economic Data

/

+

Wall Street is turning…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Initiation
Hygeia Healthcare initiated with a Neutral at Goldman Sachs » 10:47
08/09/22
08/09
10:47
08/09/22
10:47
HYHHF

Hygeia Healthcare

/

+

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Peabody Energy call volume above normal and directionally bullish » 10:45
08/09/22
08/09
10:45
08/09/22
10:45
BTU

Peabody Energy

$20.61 /

+1.425 (+7.43%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

07/07/22 B. Riley
Peabody Energy price target lowered to $33 from $34 at B. Riley
06/07/22 Jefferies
Peabody Energy upgraded to Buy from Hold at Jefferies
05/02/22 B. Riley
Peabody Energy price target raised to $34 from $32 at B. Riley
05/02/22 Benchmark
Peabody Energy price target raised to $29 from $19 at Benchmark
BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

Hot Stocks
GoodRx rallies after saying grocer issue recently addressed » 10:44
08/09/22
08/09
10:44
08/09/22
10:44
GDRX

GoodRx

$8.13 /

+0.35 (+4.50%)

GoodRx said in last…

GoodRx said in last night's earnings letter, "We are pleased to share that the grocer issue we discussed on our first quarter earnings call was very recently addressed. As communication is rolled out to the grocery chain's pharmacists, we expect GoodRx discounts to be consistently welcomed at the point of sale. We are delighted that our consumers can enjoy the prescription access and affordability benefits of GoodRx at the grocery chain, who we value as a partner. Despite this very recent positive development, we do not anticipate a meaningful volume or revenue lift in the third quarter based on the rollout timeline of relevant communications to the grocery chain's pharmacies, new user adoption and returning user levels. We expect third quarter revenue to be approximately $185 million. This assumes the grocer issue has an estimated impact of $35 million to $40 million on third quarter prescription transactions revenue. We're expecting a greater impact quarter-over-quarter because the effect on the second quarter gradually increased as the quarter developed, whereas we started the third quarter facing a significant impact. In addition to the effect of the grocer issue on prescription transactions revenue, we expect our recent consumer engagement efforts, which we will discuss on our second quarter earnings call, to negatively impact prescription transactions revenue by approximately $5 million in the third quarter." Shares of GoodRx are up 6% to $8.20 in morning trading.

ShowHide Related Items >><<
GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

10:40 Today Goldman Sachs
Goldman Sachs raises GoodRx price target to $10 amid grocer issue resolution
07:58 Today RBC Capital
GoodRx price target raised to $11 from $6.50 at RBC Capital
05:50 Today Barclays
GoodRx price target raised to $13 from $12 at Barclays
07/20/22 Barclays
GoodRx price target lowered to $12 from $15 at Barclays
GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

Hot Stocks
WeTrade Group Inc trading halted, volatility trading pause  10:44
08/09/22
08/09
10:44
08/09/22
10:44
WETG

WeTrade

$17.30 /

-0.9 (-4.95%)

 
ShowHide Related Items >><<
WETG WeTrade
$17.30 /

-0.9 (-4.95%)

  • 19
    Jul
Periodicals
Blue Owl Capital's Dyal in talks to buy stake in PAI Partners, Bloomberg says » 10:43
08/09/22
08/09
10:43
08/09/22
10:43
OWL

Blue Owl Capital

$12.52 /

+0.035 (+0.28%)

Blue Owl Capital's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

07/11/22 JPMorgan
Blue Owl Capital initiated with a Neutral at JPMorgan (Thursday)
06/08/22 JMP Securities
Blue Owl Capital initiated with an Outperform at JMP Securities
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

  • 02
    Jun
  • 08
    Dec
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

Recommendations
Goldman Sachs raises GoodRx price target to $10 amid grocer issue resolution » 10:40
08/09/22
08/09
10:40
08/09/22
10:40
GDRX

GoodRx

$8.28 /

+0.5 (+6.43%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

07:58 Today RBC Capital
GoodRx price target raised to $11 from $6.50 at RBC Capital
05:50 Today Barclays
GoodRx price target raised to $13 from $12 at Barclays
07/20/22 Barclays
GoodRx price target lowered to $12 from $15 at Barclays
07/18/22 Guggenheim
GoodRx price target lowered to $13 from $17 at Guggenheim
GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

Periodicals
Avaya taps Kirkland & Ellis to advise on options, WSJ reports » 10:37
08/09/22
08/09
10:37
08/09/22
10:37
AVYA

Avaya

/

+

Avaya has selected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVYA Avaya
/

+

AVYA Avaya
/

+

07/29/22 Craig-Hallum
Avaya downgraded to Hold from Buy at Craig-Hallum
07/29/22 Craig-Hallum
Avaya downgraded to Hold from Buy at Craig-Hallum
07/26/22 Barclays
Avaya price target lowered to $2 from $5 at Barclays
06/06/22 Citi
Avaya price target lowered to $6 from $9 at Citi
AVYA Avaya
/

+

AVYA Avaya
/

+

AVYA Avaya
/

+

Options
Warner Bros Discovery Inc put volume heavy and directionally bearish » 10:35
08/09/22
08/09
10:35
08/09/22
10:35
WBD

Warner Bros. Discovery

$13.49 /

-0.52 (-3.71%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

08/08/22 Barrington
Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington
08/05/22 Wells Fargo
Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo
08/05/22 Barclays
Warner Bros. Discovery price target lowered to $17 from $19 at Barclays
08/04/22 Credit Suisse
Warner Bros. Discovery price target lowered to $43 from $52 at Credit Suisse
WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

General news
European Fixed Income Summary: » 10:35
08/09/22
08/09
10:35
08/09/22
10:35
$ECON

Economic Data

/

+

European Fixed Income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Downgrade
Canoo downgraded to Neutral at Roth Capital on increased need for cash » 10:31
08/09/22
08/09
10:31
08/09/22
10:31
GOEV

Canoo

$3.51 /

-0.445 (-11.27%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

10:28 Today Roth Capital
Canoo downgraded to Neutral from Buy at Roth Capital
08:41 Today R.F. Lafferty
Canoo price target lowered to $15 from $17 at R.F. Lafferty
07/14/22 R.F. Lafferty
Canoo price target lowered to $17 from $20 at R.F. Lafferty
07/13/22 H.C. Wainwright
Canoo price target lowered to $10 from $15 at H.C. Wainwright
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

Downgrade
Canoo downgraded to Neutral from Buy at Roth Capital » 10:28
08/09/22
08/09
10:28
08/09/22
10:28
GOEV

Canoo

$3.51 /

-0.445 (-11.27%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

08:41 Today R.F. Lafferty
Canoo price target lowered to $15 from $17 at R.F. Lafferty
07/14/22 R.F. Lafferty
Canoo price target lowered to $17 from $20 at R.F. Lafferty
07/13/22 H.C. Wainwright
Canoo price target lowered to $10 from $15 at H.C. Wainwright
12/16/21 R.F. Lafferty
Canoo price target raised to $21 from $19 at R.F. Lafferty
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

Hot Stocks
Verona Pharma surges after ensifentrine meets endpoint in COPD study » 10:28
08/09/22
08/09
10:28
08/09/22
10:28
VRNA

Verona Pharma

$12.69 /

+5.76 (+83.12%)

Verona Pharma shares are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

06/17/22 Wedbush
Verona Pharma price target lowered to $18 from $25 at Wedbush
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 H.C. Wainwright
Verona Pharma initiated with a Buy at H.C. Wainwright
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

Earnings
Sysco reaffirms FY24 adjusted EPS guidance 30% higher than FY19 » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
SYY

Sysco

$85.16 /

-1.53 (-1.76%)

Previously provided FY24…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

06/29/22 Barclays
Sysco price target raised to $102 from $97 at Barclays
06/09/22 Barclays
Sysco price target lowered to $97 from $102 at Barclays
05/26/22 JPMorgan
Sysco upgraded to Overweight after recent pullback at JPMorgan
05/26/22 JPMorgan
Sysco upgraded to Overweight from Neutral at JPMorgan
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

Earnings
Verona Pharma reports Q2 EPS (4c), consensus (38c) » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
VRNA

Verona Pharma

$12.69 /

+5.76 (+83.12%)

The company's cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

06/17/22 Wedbush
Verona Pharma price target lowered to $18 from $25 at Wedbush
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 H.C. Wainwright
Verona Pharma initiated with a Buy at H.C. Wainwright
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

Earnings
Sysco prepared to generate sales growth of at least 10% in 2023 » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
SYY

Sysco

$85.16 /

-1.53 (-1.76%)

Food away from home is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

06/29/22 Barclays
Sysco price target raised to $102 from $97 at Barclays
06/09/22 Barclays
Sysco price target lowered to $97 from $102 at Barclays
05/26/22 JPMorgan
Sysco upgraded to Overweight after recent pullback at JPMorgan
05/26/22 JPMorgan
Sysco upgraded to Overweight from Neutral at JPMorgan
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

Hot Stocks
Liberty TripAdvisor Holdings trading resumes  10:27
08/09/22
08/09
10:27
08/09/22
10:27
 
Options
B. Riley Principal 150 Merger Corp call volume above normal and directionally bullish » 10:25
08/09/22
08/09
10:25
08/09/22
10:25
FAZE

FaZe Holdings

$14.69 /

+0.49 (+3.45%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FAZE FaZe Holdings
$14.69 /

+0.49 (+3.45%)

FAZE FaZe Holdings
$14.69 /

+0.49 (+3.45%)

General news
U.S. IBD/TIPP economic optimism index slipped to -0.4 ticks to 38.1 in August » 10:25
08/09/22
08/09
10:25
08/09/22
10:25
$ECON

Economic Data

/

+

U.S. IBD/TIPP economic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Technical Analysis
NASDAQ market internals summary » 10:17
08/09/22
08/09
10:17
08/09/22
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.